Retraction-Hydroxychloroquine or chloroquine with or without a macrolide for treatment of COVID-19: a multinational registry analysis

Mandeep R Mehra¹, Frank Ruschitzka², Amit N Patel³

Affiliations

¹ Brigham and Women's Hospital Heart and Vascular Center and Harvard Medical School, Boston, MA 02115, USA. Electronic address: mmehra@bwh.harvard.edu.
² University Heart Center, University Hospital Zurich, Zurich, Switzerland.
³ Department of Biomedical Engineering, University of Utah, Salt Lake City, UT, USA; HCA Research Institute, Nashville, TN, USA.

PMID: 32511943
PMCID: PMC7274621
DOI: 10.1016/S0140-6736(20)31324-6

Retraction of Publication

Retraction-Hydroxychloroquine or chloroquine with or without a macrolide for treatment of COVID-19: a multinational registry analysis

Mandeep R Mehra et al. Lancet. 2020.

. 2020 Jun 13;395(10240):1820.

doi: 10.1016/S0140-6736(20)31324-6. Epub 2020 Jun 5.

Authors

Mandeep R Mehra¹, Frank Ruschitzka², Amit N Patel³

Affiliations

¹ Brigham and Women's Hospital Heart and Vascular Center and Harvard Medical School, Boston, MA 02115, USA. Electronic address: mmehra@bwh.harvard.edu.
² University Heart Center, University Hospital Zurich, Zurich, Switzerland.
³ Department of Biomedical Engineering, University of Utah, Salt Lake City, UT, USA; HCA Research Institute, Nashville, TN, USA.

PMID: 32511943
PMCID: PMC7274621
DOI: 10.1016/S0140-6736(20)31324-6

No abstract available

PubMed Disclaimer

Retraction of

RETRACTED: Hydroxychloroquine or chloroquine with or without a macrolide for treatment of COVID-19: a multinational registry analysis.
Mehra MR, Desai SS, Ruschitzka F, Patel AN. Mehra MR, et al. Lancet. 2020 May 22:S0140-6736(20)31180-6. doi: 10.1016/S0140-6736(20)31180-6. Online ahead of print. Lancet. 2020. Retraction in: Lancet. 2020 Jun 13;395(10240):1820. doi: 10.1016/S0140-6736(20)31324-6. Retraction in: Lancet. 2020 Jul 18;396(10245):e2-e3. doi: 10.1016/S0140-6736(20)31528-2. PMID: 32450107 Free PMC article. Retracted.

Cited by

Inaugural Lifestyle Medicine Editorial: Lifestyle medicine in the time of COVID-19.
Birrell F. Birrell F. Lifestyle Med (Hoboken). 2020 Jul;1(1):e1. doi: 10.1002/lim2.1. Epub 2020 Jun 11. Lifestyle Med (Hoboken). 2020. PMID: 38607858 Free PMC article. No abstract available.
Efficacy and safety of hydroxychloroquine for treatment of mild SARS-CoV-2 infection and prevention of COVID-19 severity in pregnant and postpartum women: A randomized, double-blind, placebo-controlled trial.
González R, Goncé A, Gil MDM, Mazarico E, Ferriols-Pérez E, Toro P, Llurba E, Saéz E, Rodríguez-Zambrano MÁ, García-Otero L, López M, Santacruz B, Román MÁ, Payà A, Alonso S, Cruz-Lemini M, Pons-Duran C, Herrera LB, Chen H, Bardají A, Quintó L, Menendez C; COVID-Preg research group. González R, et al. Acta Obstet Gynecol Scand. 2024 Mar;103(3):602-610. doi: 10.1111/aogs.14745. Epub 2023 Dec 14. Acta Obstet Gynecol Scand. 2024. PMID: 38098221 Free PMC article. Clinical Trial.
Use of a rapid triage assessment tool to discriminate the need for hospitalisation in patients with severe COVID-19 infection presenting to an outpatient clinic: a single-centre, prospective cohort study.
Owens C, Lamb C, Sanchez J, Quintero M, Lopez-Yunez A. Owens C, et al. BMJ Open. 2023 Nov 29;13(11):e073781. doi: 10.1136/bmjopen-2023-073781. BMJ Open. 2023. PMID: 38030244 Free PMC article.
Patient-reported outcomes of neurologic and neuropsychiatric symptoms in mild COVID-19: a prospective cohort study.
Ganesh A, Rosentreter RE, Chen Y, Mehta R, McLeod GA, Wan MW, Krett JD, Mahjoub Y, Lee AS, Schwartz IS, Richer LP, Metz LM, Smith EE, Hill MD; Alberta HOPE COVID-19 Collaborators. Ganesh A, et al. CMAJ Open. 2023 Aug 8;11(4):E696-E705. doi: 10.9778/cmajo.20220248. Print 2023 Jul-Aug. CMAJ Open. 2023. PMID: 37553227 Free PMC article.
Raising concerns on questionable ethics approvals - a case study of 456 trials from the Institut Hospitalo-Universitaire Méditerranée Infection.
Frank F, Florens N, Meyerowitz-Katz G, Barriere J, Billy É, Saada V, Samuel A, Robert J, Besançon L. Frank F, et al. Res Integr Peer Rev. 2023 Aug 3;8(1):9. doi: 10.1186/s41073-023-00134-4. Res Integr Peer Rev. 2023. PMID: 37533089 Free PMC article.

See all "Cited by" articles

References

1. Mehra MR, Desai SS, Ruschitzka F, Patel AN. Hydroxychloroquine or chloroquine with or without a macrolide for treatment of COVID-19: a multinational registry analysis. Lancet. 2020 doi: 10.1016/S0140-6736(20)31180-6. published online May 22. - DOI - PMC - PubMed

Publication types

Actions

LinkOut - more resources

Full Text Sources
Other Literature Sources
- The Lens - Patent Citations

Save citation to file

Email citation

Add to Collections

Add to My Bibliography

Your saved search

Create a file for external citation management software

Your RSS Feed

Retraction-Hydroxychloroquine or chloroquine with or without a macrolide for treatment of COVID-19: a multinational registry analysis

Affiliations

Retraction-Hydroxychloroquine or chloroquine with or without a macrolide for treatment of COVID-19: a multinational registry analysis

Authors

Affiliations

Retraction of

Similar articles

Cited by

References

Publication types

LinkOut - more resources

Full Text Sources

Other Literature Sources